Annual report pursuant to Section 13 and 15(d)

Consolidated Consolidated Statements Of Equity (Deficit)

v3.22.1
Consolidated Consolidated Statements Of Equity (Deficit) - USD ($)
$ in Thousands
Total
Bridge Notes
Promissory Notes
Retroactive application of the recapitalization
Previously Reported
Adoption of accounting standards
Adjusted balance
Common Stock warrants
 [1]
Common Stock warrants
Merger
Preferred Stock
Common Stock
Common Stock
Bridge Notes
Common Stock
Promissory Notes
Common Stock
Retroactive application of the recapitalization
Common Stock
Previously Reported
Common Stock
Adjusted balance
Common Stock
Common Stock warrants
 [1]
Common Stock
Common Stock warrants
Merger
Common Stock
Common Class A
Common Stock
Common Class A
Retroactive application of the recapitalization
Common Stock
Common Class A
Previously Reported
Common Stock
Common Class A
Adjusted balance
Common Stock
Common Class B
Common Stock
Common Class B
Retroactive application of the recapitalization
Common Stock
Common Class B
Previously Reported
Common Stock
Common Class B
Adjusted balance
Common Stock
Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Bridge Notes
Additional Paid-in Capital
Promissory Notes
Additional Paid-in Capital
Retroactive application of the recapitalization
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Adjusted balance
Additional Paid-in Capital
Common Stock warrants
 [1]
Additional Paid-in Capital
Common Stock warrants
Merger
Additional Paid-in Capital
Preferred Stock
Treasury Stock
Treasury Stock
Retroactive application of the recapitalization
Treasury Stock
Previously Reported
Treasury Stock
Adjusted balance
Accumulated Deficit
Accumulated Deficit
Retroactive application of the recapitalization
Accumulated Deficit
Previously Reported
Accumulated Deficit
Adoption of accounting standards
Accumulated Deficit
Adjusted balance
Beginning balance, Carrying amount at Dec. 31, 2019 $ 0     $ (171,321) $ 171,321   $ 0                                                                            
Beginning balance, Shares outstanding (in shares) at Dec. 31, 2019 0     (76,971,000) 76,971,000   0                                                                            
Ending balance, Carrying amount at Dec. 31, 2020 $ 0                                                                                        
Ending balance, Shares outstanding (in shares) at Dec. 31, 2020 0                                                                                        
Balance at beginning of period at Dec. 31, 2019 $ (18,295)     $ 171,321 $ (189,616) $ (650) $ (18,945)       $ 3     $ 3 $ 0 $ 3     $ 0 $ (1) $ 1 $ 0 $ 0 $ (1) $ 1 $ 0   $ 185,501     $ 158,820 $ 26,681 $ 185,501       $ 0 $ 12,500 $ (12,500) $ 0 $ (203,799) $ 0 $ (203,799) $ (650) $ (204,449)
Balance at beginning of period (in shares) at Dec. 31, 2019                     31,074,000     31,074,000 0 31,074,000     0 (72,319,000) 72,319,000 0 0 (83,987,000) 83,987,000 0                     0 (11,500,000) 11,500,000 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                          
Stock-based compensation 2,390                                                     2,390                                  
Issuance of subsidiary preferred stock (Note 16)                   $ 3,247                                                   $ 3,247                  
Issuance of common stock upon exercise of stock options 30                                                     30                                  
Issuance of common stock upon exercise of stock options (in shares)                     188,000                                                                    
Issuance of common stock upon vesting of restricted stock awards (in shares)                     2,376,000                                                                    
Issuance of common stock in connection with acquisition (in shares)                     55,000                                                                    
Stock issued during period (in shares)                                                     999,000                                    
Net loss (19,535)                                                                               (19,535)        
Balance at end of period at Dec. 31, 2020 $ (32,813)                   $ 3               $ 0       $ 0         191,168                 $ 0       (223,984)        
Balance at end of period (in shares) at Dec. 31, 2020 34,692,000                   34,692,000               0       0                           0                
Ending balance, Carrying amount at Dec. 31, 2021 $ 0                                                                                        
Ending balance, Shares outstanding (in shares) at Dec. 31, 2021 0                                                                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                          
Stock-based compensation $ 42,582                                                     42,582                                  
Issuance of common stock due to Bridge Notes 106,353                   $ 2                                 106,351                                  
Issuance of common stock due to Bridge Notes (in shares)                     20,343,000                                                                    
Issuance of common stock upon exercise of stock options $ 130                                                     130                                  
Issuance of common stock upon exercise of stock options (in shares) 1,045,000                   1,044,000                                                                    
Issuance of common stock upon vesting of restricted stock awards (in shares)                     546,000                                                                    
Issuance of common stock upon vesting of restricted stock units (in shares)                     111,000                                                                    
Issuance of common stock on conversion (in shares)                       7,736,000 958,000       3,251,000 11,187,000                                                      
Issuance of common stock on conversion   $ 77,097           $ 2,289 $ 38,329     $ 1           $ 1                     $ 77,096         $ 2,289 $ 38,328                    
Issuance of sponsor earn-out shares $ (17,659)                                                     (17,659)                                  
Reverse recapitalization, net (in shares)                     34,584,000                                                                    
Reverse recapitalization, net (Note 4) 200,917                   $ 4                                 202,195                         (1,282)        
Conversion of bridge notes and accrued interest into common stock     $ 8,038                                                     $ 8,038                              
Net loss (245,643)                                                                               (245,643)        
Balance at end of period at Dec. 31, 2021 $ 179,620                   $ 11               $ 0       $ 0         $ 650,518                 $ 0       $ (470,909)        
Balance at end of period (in shares) at Dec. 31, 2021 114,452,000                   114,452,000               0       0                           0                
Balance at beginning of period (in shares) at Sep. 08, 2021 31,625,000                                                                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                          
Reverse recapitalization, net (in shares) 34,584,000                                                                                        
[1] Inclusive of warrants exercised for preferred stock then exchanged into common stock in connection with merger.